$HLN

Haleon is Buying Better Shelf Space, Can the Visibility Help it Against Procter & Gamble and Colgate-Palmolive?

Haleon plc (HLN) has secured better shelf space at Walmart (WMT), Target (TGT), and other retailers, leading to a US market share increase from 11.4% to 12% by August, per NielsenIQ data. The company achieved this through lower prices, promotions, and exclusivity, but profitability impact is unclear. Competitors like Procter & Gamble and Colgate-Palmolive saw flat or declining shares. Haleon's strategy may face challenges from promotional dependence and competitor responses.

Original reporting
Published Sep 24, 2026, 6:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 24, 2026, 7:33 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Haleon is Buying Better Shelf Space, Can the Visibility Help it Against Procter & Gamble and Colgate-Palmolive? — source image
Decision brief

The 30-second read

$HLNNeutralLow
01

Why it matters

The strategy could drive volume growth but introduces margin pressure; investors should watch upcoming earnings for margin trends.

02

Market read

Provides a fresh data point on Haleon's US market‑share growth tied to retail tactics, relevant for sector traders.

03

What to watch

Potential for retailers to renegotiate terms or reverse shelf placements if sales do not meet expectations.

Relevance 4/10Novelty 2/10Timing: recently disclosed

Background

Haleon (HLN) is expanding its US consumer‑health presence through better shelf placement at major retailers.

Company-level read

Ticker impact

$HLNNeutralMedium confidence
Context

Haleon reported increased US market share to 12% after securing better shelf space at Walmart and Target.

Expected impact

Potential modest upside if share gains translate to higher revenue, but margin concerns may cap upside.

Evidence & confidence

The article provides first‑time data on shelf‑placement driven share gain, but lacks quantitative profit impact.

Market effects

Highlights competitive dynamics in US consumer‑health retail, suggesting peers may need similar shelf strategies.

US retail channel focus; limited immediate effect on other regions.

Modest, confined to consumer‑health sector investors.

Counterpoint

Higher promotional spend may erode margins, making the share gain unsustainable.

Key entities

  • Haleon plc

    Consumer‑health company seeking shelf‑placement advantage.

Related articles

$CLMed

Piper Sandler cuts Colgate-Palmolive stock price target on cost pressures

Piper Sandler reduced its price target for Colgate-Palmolive (CL) to $95 from $98, citing cost pressures from elevated oil prices and inventory headwinds. The firm maintained an Overweight rating and a 2026 EPS estimate of $3.85, but lowered its 2027 EPS estimate to $4.12 from $4.23. CL trades at $87.47 with a P/E ratio of 34.6 and a gross profit margin of 60%. Other analysts have maintained positive outlooks, with RBC and UBS setting higher price targets.

$CLMedAI 8/10

Colgate-Palmolive Explores Sale Of Softsoap, Irish Spring, Speed Stick Brands: Report

Colgate-Palmolive (CL) is exploring the sale of brands like Softsoap, Irish Spring, and Speed Stick, potentially fetching over $1 billion. The company is working with Goldman Sachs (GS) on the divestiture. Personal care accounted for 17% of CL's 2025 net sales, which totaled $20.38 billion. The move is part of a broader productivity and restructuring program aimed at generating annual pre-tax savings of $200 million to $300 million by 2028.

$CLMedAI 8/10

Colgate-Palmolive reportedly weighs US$1B personal care offload.

Colgate-Palmolive is reportedly considering the sale of select mass-market personal care brands, including Softsoap, Irish Spring, and Speed Stick, for over $1 billion. The company is working with Goldman Sachs on the potential divestment to focus on higher-margin businesses amid North American competition. Personal care accounted for 17% of its 2025 net sales of $20.38 billion.

$CLMed

CL Stock Alert: Colgate-Palmolive Reportedly Considers $1 Billion Brand Sale

Colgate-Palmolive (CL) is reportedly exploring the sale of non-core personal care brands, valued at over $1 billion, with Goldman Sachs' advisory. The move aims to reallocate capital toward higher-growth segments. CL shares are down 12% year-to-date, trading below major moving averages, but offer a 2.44% dividend yield. Institutional investors remain bullish, and the consensus rating is 'Moderate Buy' with a mean price target of $160.

$CLMedAI 8/10

Colgate-Palmolive Seeks Value Through Portfolio Reshaping

Colgate-Palmolive (NYSE:CL) is exploring the sale of mass-market personal care brands, including Softsoap, Irish Spring, and Speed Stick, potentially generating over $1 billion. The move aims to simplify its portfolio and focus on higher-growth areas like oral care and pet nutrition, amid competitive pressure in North America. The company reported a 4.9% increase in net sales, but organic sales in North America declined 3%. Proceeds could be used for debt reduction, share repurchases, or acquisi